Biomaterials used for dendritic cell vaccine for cancer immunotherapy
The invention
- Name of invention
- Biomaterials used for dendritic cell vaccine for cancer immunotherapy
- Biomatériaux utilisés pour un vaccin à base de cellules dendritiques pour l'immunothérapie du cancer
Invention description
- Description
- Vaccine which enhances dendritic cell maturation using silica nanomatrices, offering a safe and biocompatible approach to improve treatment efficiency, effectiveness and survival rates in cancer immunotherapy.
INVENTORS
The Education University of Hong Kong inventor 3700503414_2937
Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.